Oyster Point Pharma, Inc.
(NASDAQ) OYST
Oyster Point Pharma, Inc. Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$19.58M
Net Income (TTM)
$188.97M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
OYST News
OYST: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Oyster Point Pharma, Inc.
Industry
Biotechnology
Sector
Health CareEmployees
62
CEO
Jeffrey A. Nau, PhD
Website
www.oysterpointrx.comHeadquarters
Princeton, NJ 08540, US
OYST Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
-73%
Return on Capital
-50%
Return on Assets
-47%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$23.01M
Operating Income
$96.92M
EBITDA
$96.78M
Operating Cash Flow
$89.37M
Capital Expenditure
$1.49M
Free Cash Flow
$90.86M
Cash & ST Invst.
$193.37M
Total Debt
$92.73M
Oyster Point Pharma, Inc. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$5.59M
-68.8%
Gross Profit
$4.24M
-76.4%
Gross Margin
75.89%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
303
N/A
Net Income
$40.24M
-127.7%
EBITDA
$33.18M
-101.0%
Quarterly Fundamentals
Net Cash
$25.92M
-118.3%
Accounts Receivable
$13.18M
+427.4%
Inventory
$6.96M
N/A
Long Term Debt
$94.03M
+123.4%
Short Term Debt
$692.00K
+43.9%
Return on Assets
-46.89%
N/A
Return on Invested Capital
-50.01%
N/A
Free Cash Flow
$35.97M
-225.1%
Operating Cash Flow
$35.97M
-232.8%